ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A Community Connection

Catherine Kolonko  |  November 19, 2025

The social prescription approach takes healthcare beyond the clinical setting

Heidi Prather, DO, FAAPMR

Dr. Heidi Prather

As roughly 60% of the U.S. adult population struggles with at least one chronic disease, the country’s overall approach to treatment is sick care not healthcare, said Heidi Prather, DO, FAAPMR, Sports Medicine, CAQ, attending physician, Hospital for Special Surgery (HSS), Department of Physiatry, New York; professor of physical medicine and rehabilitation, Weill Cornell Medicine, New York; and medical director, HSS Lifestyle Medicine Program. She also serves as a diplomat to the American College of Lifestyle Medicine, Chesterfield, Mo.1

In her keynote speech to the members of the ARP at ACR Convergence 2025, Dr. Prather discussed social prescription, an approach to the practice of medicine that expands the focus beyond the medical treatment of disease. With social prescription, a healthcare professional refers a patient to non-medical community programs designed to address various social determinants of health, such as loneliness, social isolation or insecure finances.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“It should be a personalized plan that promotes health, well-being and community connection,” Dr. Prather said. Patient engagement is central to success.

The Research

A U.K. study looked at implementation challenges of 20 link workers and social prescribing experiences of 19 clients. The term link worker covers a wide scope of industries, with people of various types of credentials who could be a health coach, navigator, social worker, nurse, physician or other medical worker. The study’s organizational approach emphasized a client’s personal responsibility for his or her health.2

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“That is exactly what needs to happen,” Dr. Prather said. “But we as healthcare providers do a very poor job of enabling people to be a part of their own healthcare solution. That is a part of our system problem; that’s not an us problem.”

Researchers in the U.K. study found that a key benefit of social prescribing was significant help to some people with chronic disease. Challenges included embedding the approach within primary care and voluntary sector systems.

Other research on social prescribing showed that patients were more likely to enroll in the study program if they believed they would benefit from what was prescribed and if they had access to supported transportation to the first visit or activity, said Dr. Prather. Factors that contributed to the patient staying with a program included skilled and knowledgeable activity leaders and if the patient saw a change in symptoms or conditions.3

Page: 1 2 3 | Single Page
Share: 

Filed under:ACR ConvergenceMeeting Reports Tagged with:ACR Convergence 2025patient carePractice Managementsocial perscription

Related Articles

    Psoriatic Arthritis Drugs at a Glance, 2023

    April 21, 2023

    Biosimilars have become a therapeutic turning point for many patients who are living with rheumatic illnesses. Psoriatic arthritis (PsA) is a complex, multi-faceted chronic inflammatory musculoskeletal and skin disease where the treatment has changed considerably over the past few years. Psoriatic arthritis has an impact on about 30% of people with psoriasis.1 In 2019, the…

    Healthy Lifestyle Behaviors Lower Women’s Risk of Developing Rheumatoid Arthritis

    August 25, 2022

    Using data from cohorts with detailed lifestyle data and lengthy follow-up, Hahn et al. demonstrated that healthy lifestyle behaviors are associated with a lower risk of developing rheumatoid arthritis (RA), concluding that a substantial proportion of RA may be preventable.

    The Role of Social Work in Patient-Centered Rheumatology Care

    December 1, 2013

    Social workers’ ability to build trusted relationships with patients helps enhance care coordination and can improve patient outcomes

    Psoriatic Arthritis Treatment Update

    October 13, 2021

    About 30% of patients with psoriasis have psoriatic arthritis (PsA), a complex, multi-faceted, chronic, inflammatory musculoskeletal and skin disease for which the treatment has changed considerably over the past few years.1 Biosimilars and other new drugs have become a therapeutic turning point for many patients suffering from rheumatic illnesses, including PsA. The treatment of PsA…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences